Evidence map›Paper›PMID 38561668›Full record

ArticleThe journal of physiological sciences : JPS2024

Negative regulation of thyroid adenoma-associated protein (THADA) in the cardiac glycoside-induced anti-cancer effect.

Mizuki Katoh, Takuto Fujii, Yoshiaki Tabuchi, Takahiro Shimizu, Hideki Sakai

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of physiological sciences : JPS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Digoxin and its NaBioorganic & medicinal chemistry · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mizuki KatohDepartment of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.
Takuto FujiiDepartment of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan. fujiitk@pha.u-toyama.ac.jp.ORCID 0000-0002-0547-1691
Yoshiaki TabuchiDivision of Molecular Genetics Research, Life Science Research Center, University of Toyama, Toyama, 930-0194, Japan.
Takahiro ShimizuDepartment of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.
Hideki SakaiDepartment of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.ORCID 0000-0002-9753-7941
University of Toyama · JP

Funding

Japan Society for the Promotion of Science 22H02801Japan Society for the Promotion of Science 22K06827Japan Society for the Promotion of Science 23K06330The establishment of university fellowships towards the creation of science technology innovation (University of Toyama) JPMJFS2115
6 · The paper itself

Abstract

Cardiac glycosides, known as inhibitors of Na

Indexed as

Cardiac GlycosidesThyroid NeoplasmsGlycosidesHumansNeoplasm ProteinsOuabainSodium-Potassium-Exchanging ATPaseCardiac GlycosidesGlycosidesNeoplasm ProteinsOuabainSodium-Potassium-Exchanging ATPaseTHADA protein, humanCancer cellsCardiac glycosideL-type amino acid transporter 1Na+,K+-ATPaseThyroid adenoma-associated protein

Identifiers

PMID38561668
PMCPMC10985892
OpenAlexW4393377742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.